Ryan Dunlap serves as Executive at Galena Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Ryan Dunlap has executed 9 insider transactions totaling $276.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 1, 2016 involved selling 126,875 shares valued at $276.6K.
Ryan Dunlap currently holds 18,702 shares of Galena Biopharma, Inc. (GALE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ryan Dunlap has been a net seller of GALE stock. They have purchased $0 and sold $276.6K worth of shares.
Ryan Dunlap's most recent insider trade was on Jun 1, 2016, when they sold 126,875 shares at $2.18 per share.
Get notified when new Form 4 filings are submitted
| $1.71 |
| Discretionary |
| Jun 1, 2016 | GALE | $121.4K | Option Exercise | 65,625 | $1.85 | Discretionary |
| Jun 1, 2016 | GALE | $54.7K | Option Exercise | 31,250 | $1.75 | Discretionary |
| Dec 31, 2014 | GALE | $4.9K | Other | 3,846 | $1.28 | Discretionary |
| Jun 30, 2014 | GALE | $6.4K | Other | 2,461 | $2.60 | Discretionary |
| Dec 31, 2013 | GALE | $5.1K | Other | 2,728 | $1.88 | Discretionary |
| Jun 30, 2013 | GALE | $1.8K | Other | 1,369 | $1.35 | Discretionary |
| Dec 31, 2012 | GALE | $1.6K | Other | 1,246 | $1.30 | Discretionary |